Model Medicines Accepted To Join The Alliance for Artificial Intelligence in Healthcare (AAIH)

Model Medicines has been accepted to join The Alliance for Artificial Intelligence in Healthcare (AAIH). The AAIH is a coalition of technology developers, pharmaceutical companies, and research organizations who have expressed the common goal of realizing the potential for AI and machine learning in healthcare. By engaging with a wide array of participants across the healthcare spectrum, the AAIH works to actualize the promise of artificial intelligence in medicine thereby improving patients’ lives and creating more efficient, sustainable, and accessible healthcare systems. Model Medicines joins an elite group of companies including: Amazon Web Services (AWS), Bayer, Cyclica, GE Healthcare, Healx, Johnson & Johnson, Novo Nordisk, Recursion, Insilico Medicine, Numerate, The Johns Hopkins University, University of Pittsburgh, Tulane University, BlackThorn Therapeutics, intelligencia.ai, Genialis, Beyond Limits, Auransa Inc., Envisagenics, and QuartzBio (part of Precision for Medicine). This article originally appeared on The Alliance for Artificial Intelligence in Healthcare, prior to the rebrand of Repurpose.AI to Model Medicines, read the full article here.